+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?



How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?



Journal of Gastrointestinal Surgery 2(4): 314-317




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046280983

Download citation: RISBibTeXText

PMID: 9917185


Related references

The inflammatory bowel disease questionnaire: A valid and reliable measure in ulcerative colitis patients in the North East of England. Scandinavian Journal of Gastroenterology 33(9): 961-966, 1998

Use of dysplasia as an indicator of risk for malignancy in patients with ulcerative colitis. Winawer, S J , D Schottenfeld And P Sherlock (Ed ) Progress in Cancer Research And Therapy, Vol 13 Colorectal Cancer: Prevention, Epidemiology, And Screening; International Symposium, New York, N Y , Usa, March 6-7, 1979 Xxii+410p Raven Press: New York, N Y , Usa Illus P347-354, 1980

Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. Journal of Crohn's and Colitis 7(12): E684-E691, 2013

Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. American Journal of Gastroenterology 90(3): 377-380, 1995

The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. American Journal of Gastroenterology 94(6): 1643-1649, 1999

Pouchitis may increase the risk of dysplasia after restorative proctocolectomy in patients with ulcerative colitis. Colorectal Disease 14(1): 92-97, 2012

The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. American Journal of Gastroenterology 92(8): 1285-1288, 1997

Colorectal cancer and dysplasia risk in patients with ulcerative colitis at a tertiary referral center in Turkey. Turkish Journal of Gastroenterology 30(2): 118-119, 2019

Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clinical Gastroenterology and Hepatology 12(5): 756-764, 2014

Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey. Turkish Journal of Gastroenterology 30(2): 139-147, 2019

Cancer Risk Following Resection of Polypoid Dysplasia in Patients with Long-Standing Ulcerative Colitis a Meta-Analysis. 2013

Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer. Intestinal Research 14(3): 264-269, 2016

Incidence of and risk factors for dysplasia in mucosectomy area in ulcerative colitis patients undergoing restorative proctocolectomy. International Journal of Colorectal Disease 22(4): 439-443, 2007

A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer. Gastroenterology 153(6): 1634-1646.E8, 2017

Sialomucins in the assessment of dysplasia and cancer-risk patients with ulcerative colitis treated with colectomy and ileo-rectal anastomosis. Histopathology 9(2): 223-235, 1985